治療薬物モニタリング（TDM）の世界市場 2020年

• 英文タイトル：Global Theraputic Drug Monitorings Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201115265 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、120ページ • 納品方法：Eメール • 産業分類：医療

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、治療薬物モニタリング（TDM）の世界市場を調査対象にし、治療薬物モニタリング（TDM）の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（化学発光イムノアッセイ（CLIA）、蛍光イムノアッセイ（FPIA）、ラジオイムノアッセイ（RIA）、比色イムノアッセイ、その他イムノアッセイ）、用途別分析（抗癲癇薬、免疫抑制薬、抗腫瘍薬、向精神薬、抗生物質、抗真菌薬、心血管薬、抗喘息薬、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Roche AG、DiaSorin、Beckman Coulter、Siemens Healthineers、Sekisui Medical、Thermo Fisher Scientific、Grifols、BioMérieux、Agilent Technologies、Fujirebio、Chromsystems、ALPCO、Ortho-Clinical Diagnostics、MedTox、Bio-Rad、Tosoh、Quest Diagnostics、BIOHIT Healthcare、R-Biopharm AG、Sysmex、Wieslab、Omnica、ARK Diagnostics、Probe Scientific ・企業別売上、市場シェア ・治療薬物モニタリング（TDM）の地域別市場分析 ・治療薬物モニタリング（TDM）の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・治療薬物モニタリング（TDM）のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・治療薬物モニタリング（TDM）のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・治療薬物モニタリング（TDM）の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・治療薬物モニタリング（TDM）の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・治療薬物モニタリング（TDM）の種類別市場規模2015-2020：化学発光イムノアッセイ（CLIA）、蛍光イムノアッセイ（FPIA）、ラジオイムノアッセイ（RIA）、比色イムノアッセイ、その他イムノアッセイ ・治療薬物モニタリング（TDM）の用途別市場規模2015-2020：抗癲癇薬、免疫抑制薬、抗腫瘍薬、向精神薬、抗生物質、抗真菌薬、心血管薬、抗喘息薬、その他 ・治療薬物モニタリング（TDM）の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論

Market Overview
The global Theraputic Drug Monitorings market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Theraputic Drug Monitorings market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Theraputic Drug Monitorings market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Theraputic Drug Monitorings market has been segmented into:
Chemiluminescence Immunoassay (CLIA)
Fluorescence Immunoassay (FPIA)
Radioimmunoassay (RIA)
Colorimetric Immunoassay
Other Immunoassays

By Application, Theraputic Drug Monitorings has been segmented into:
Antiepileptic Drugs
Immunosuppressant
Antitumor Drugs
Psychotropic Drugs
Antibiotic
Antifungal
Cardiovascular Drugs
Antiasthmatic
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Theraputic Drug Monitorings market presented in the report. This section sheds light on the sales growth of different regional and country-level Theraputic Drug Monitorings markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Theraputic Drug Monitorings market.

The report offers in-depth assessment of the growth and other aspects of the Theraputic Drug Monitorings market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Theraputic Drug Monitorings Market Share Analysis
Theraputic Drug Monitorings competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Theraputic Drug Monitorings sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Theraputic Drug Monitorings sales, revenue and market share for each player covered in this report.

The major players covered in Theraputic Drug Monitorings are:
Roche AG
DiaSorin
Beckman Coulter
Siemens Healthineers
Sekisui Medical
Thermo Fisher Scientific
Grifols
BioMérieux
Agilent Technologies
Fujirebio
Chromsystems
ALPCO
Ortho-Clinical Diagnostics
MedTox
Bio-Rad
Tosoh
Quest Diagnostics
BIOHIT Healthcare
R-Biopharm AG
Sysmex
Wieslab
Omnica
ARK Diagnostics
Probe Scientific

レポート目次

---

Table of Contents

1 Theraputic Drug Monitorings Market Overview
1.1 Product Overview and Scope of Theraputic Drug Monitorings
1.2 Classification of Theraputic Drug Monitorings by Type
1.2.1 Global Theraputic Drug Monitorings Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Theraputic Drug Monitorings Revenue Market Share by Type in 2019
1.2.3 Chemiluminescence Immunoassay (CLIA)
1.2.4 Fluorescence Immunoassay (FPIA)
1.2.5 Radioimmunoassay (RIA)
1.2.6 Colorimetric Immunoassay
1.2.7 Other Immunoassays
1.3 Global Theraputic Drug Monitorings Market by Application
1.3.1 Overview: Global Theraputic Drug Monitorings Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Antiepileptic Drugs
1.3.3 Immunosuppressant
1.3.4 Antitumor Drugs
1.3.5 Psychotropic Drugs
1.3.6 Antibiotic
1.3.7 Antifungal
1.3.8 Cardiovascular Drugs
1.3.9 Antiasthmatic
1.3.10 Others
1.4 Global Theraputic Drug Monitorings Market by Regions
1.4.1 Global Theraputic Drug Monitorings Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Theraputic Drug Monitorings (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Theraputic Drug Monitorings Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Theraputic Drug Monitorings Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Theraputic Drug Monitorings Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Theraputic Drug Monitorings Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Theraputic Drug Monitorings Status and Prospect (2015-2025)
2 Company Profiles
2.1 Roche AG
2.1.1 Roche AG Details
2.1.2 Roche AG Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Roche AG SWOT Analysis
2.1.4 Roche AG Product and Services
2.1.5 Roche AG Theraputic Drug Monitorings Revenue, Gross Margin and Market Share (2018-2019)
2.2 DiaSorin
2.2.1 DiaSorin Details
2.2.2 DiaSorin Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 DiaSorin SWOT Analysis
2.2.4 DiaSorin Product and Services
2.2.5 DiaSorin Theraputic Drug Monitorings Revenue, Gross Margin and Market Share (2018-2019)
2.3 Beckman Coulter
2.3.1 Beckman Coulter Details
2.3.2 Beckman Coulter Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Beckman Coulter SWOT Analysis
2.3.4 Beckman Coulter Product and Services
2.3.5 Beckman Coulter Theraputic Drug Monitorings Revenue, Gross Margin and Market Share (2018-2019)
2.4 Siemens Healthineers
2.4.1 Siemens Healthineers Details
2.4.2 Siemens Healthineers Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Siemens Healthineers SWOT Analysis
2.4.4 Siemens Healthineers Product and Services
2.4.5 Siemens Healthineers Theraputic Drug Monitorings Revenue, Gross Margin and Market Share (2018-2019)
2.5 Sekisui Medical
2.5.1 Sekisui Medical Details
2.5.2 Sekisui Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Sekisui Medical SWOT Analysis
2.5.4 Sekisui Medical Product and Services
2.5.5 Sekisui Medical Theraputic Drug Monitorings Revenue, Gross Margin and Market Share (2018-2019)
2.6 Thermo Fisher Scientific
2.6.1 Thermo Fisher Scientific Details
2.6.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Thermo Fisher Scientific SWOT Analysis
2.6.4 Thermo Fisher Scientific Product and Services
2.6.5 Thermo Fisher Scientific Theraputic Drug Monitorings Revenue, Gross Margin and Market Share (2018-2019)
2.7 Grifols
2.7.1 Grifols Details
2.7.2 Grifols Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Grifols SWOT Analysis
2.7.4 Grifols Product and Services
2.7.5 Grifols Theraputic Drug Monitorings Revenue, Gross Margin and Market Share (2018-2019)
2.8 BioMérieux
2.8.1 BioMérieux Details
2.8.2 BioMérieux Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 BioMérieux SWOT Analysis
2.8.4 BioMérieux Product and Services
2.8.5 BioMérieux Theraputic Drug Monitorings Revenue, Gross Margin and Market Share (2018-2019)
2.9 Agilent Technologies
2.9.1 Agilent Technologies Details
2.9.2 Agilent Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Agilent Technologies SWOT Analysis
2.9.4 Agilent Technologies Product and Services
2.9.5 Agilent Technologies Theraputic Drug Monitorings Revenue, Gross Margin and Market Share (2018-2019)
2.10 Fujirebio
2.10.1 Fujirebio Details
2.10.2 Fujirebio Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Fujirebio SWOT Analysis
2.10.4 Fujirebio Product and Services
2.10.5 Fujirebio Theraputic Drug Monitorings Revenue, Gross Margin and Market Share (2018-2019)
2.11 Chromsystems
2.11.1 Chromsystems Details
2.11.2 Chromsystems Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Chromsystems SWOT Analysis
2.11.4 Chromsystems Product and Services
2.11.5 Chromsystems Theraputic Drug Monitorings Revenue, Gross Margin and Market Share (2018-2019)
2.12 ALPCO
2.12.1 ALPCO Details
2.12.2 ALPCO Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 ALPCO SWOT Analysis
2.12.4 ALPCO Product and Services
2.12.5 ALPCO Theraputic Drug Monitorings Revenue, Gross Margin and Market Share (2018-2019)
2.13 Ortho-Clinical Diagnostics
2.13.1 Ortho-Clinical Diagnostics Details
2.13.2 Ortho-Clinical Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Ortho-Clinical Diagnostics SWOT Analysis
2.13.4 Ortho-Clinical Diagnostics Product and Services
2.13.5 Ortho-Clinical Diagnostics Theraputic Drug Monitorings Revenue, Gross Margin and Market Share (2018-2019)
2.14 MedTox
2.14.1 MedTox Details
2.14.2 MedTox Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 MedTox SWOT Analysis
2.14.4 MedTox Product and Services
2.14.5 MedTox Theraputic Drug Monitorings Revenue, Gross Margin and Market Share (2018-2019)
2.15 Bio-Rad
2.15.1 Bio-Rad Details
2.15.2 Bio-Rad Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Bio-Rad SWOT Analysis
2.15.4 Bio-Rad Product and Services
2.15.5 Bio-Rad Theraputic Drug Monitorings Revenue, Gross Margin and Market Share (2018-2019)
2.16 Tosoh
2.16.1 Tosoh Details
2.16.2 Tosoh Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Tosoh SWOT Analysis
2.16.4 Tosoh Product and Services
2.16.5 Tosoh Theraputic Drug Monitorings Revenue, Gross Margin and Market Share (2018-2019)
2.17 Quest Diagnostics
2.17.1 Quest Diagnostics Details
2.17.2 Quest Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Quest Diagnostics SWOT Analysis
2.17.4 Quest Diagnostics Product and Services
2.17.5 Quest Diagnostics Theraputic Drug Monitorings Revenue, Gross Margin and Market Share (2018-2019)
2.18 BIOHIT Healthcare
2.18.1 BIOHIT Healthcare Details
2.18.2 BIOHIT Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 BIOHIT Healthcare SWOT Analysis
2.18.4 BIOHIT Healthcare Product and Services
2.18.3 BIOHIT Healthcare Theraputic Drug Monitorings Revenue, Gross Margin and Market Share (2018-2019)
2.19 R-Biopharm AG
2.19.1 R-Biopharm AG Details
2.19.2 R-Biopharm AG Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 R-Biopharm AG SWOT Analysis
2.19.4 R-Biopharm AG Product and Services
2.19.5 R-Biopharm AG Theraputic Drug Monitorings Revenue, Gross Margin and Market Share (2018-2019)
2.20 Sysmex
2.20.1 Sysmex Details
2.20.2 Sysmex Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Sysmex SWOT Analysis
2.20.4 Sysmex Product and Services
2.20.5 Sysmex Theraputic Drug Monitorings Revenue, Gross Margin and Market Share (2018-2019)
2.21 Wieslab
2.21.1 Wieslab Details
2.21.2 Wieslab Major Business and Total Revenue (Financial Highlights) Analysis
2.21.3 Wieslab SWOT Analysis
2.21.4 Wieslab Product and Services
2.21.5 Wieslab Theraputic Drug Monitorings Revenue, Gross Margin and Market Share (2018-2019)
2.22 Omnica
2.23 ARK Diagnostics
2.24 Probe Scientific
3 Market Competition, by Players
3.1 Global Theraputic Drug Monitorings Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Theraputic Drug Monitorings Players Market Share
3.2.2 Top 10 Theraputic Drug Monitorings Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Theraputic Drug Monitorings Revenue and Market Share by Regions
4.2 North America Theraputic Drug Monitorings Revenue and Growth Rate (2015-2020)
4.3 Europe Theraputic Drug Monitorings Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Theraputic Drug Monitorings Revenue and Growth Rate (2015-2020)
4.5 South America Theraputic Drug Monitorings Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Theraputic Drug Monitorings Revenue and Growth Rate (2015-2020)
5 North America Theraputic Drug Monitorings Revenue by Countries
5.1 North America Theraputic Drug Monitorings Revenue by Countries (2015-2020)
5.2 USA Theraputic Drug Monitorings Revenue and Growth Rate (2015-2020)
5.3 Canada Theraputic Drug Monitorings Revenue and Growth Rate (2015-2020)
5.4 Mexico Theraputic Drug Monitorings Revenue and Growth Rate (2015-2020)
6 Europe Theraputic Drug Monitorings Revenue by Countries
6.1 Europe Theraputic Drug Monitorings Revenue by Countries (2015-2020)
6.2 Germany Theraputic Drug Monitorings Revenue and Growth Rate (2015-2020)
6.3 UK Theraputic Drug Monitorings Revenue and Growth Rate (2015-2020)
6.4 France Theraputic Drug Monitorings Revenue and Growth Rate (2015-2020)
6.5 Russia Theraputic Drug Monitorings Revenue and Growth Rate (2015-2020)
6.6 Italy Theraputic Drug Monitorings Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Theraputic Drug Monitorings Revenue by Countries
7.1 Asia-Pacific Theraputic Drug Monitorings Revenue by Countries (2015-2020)
7.2 China Theraputic Drug Monitorings Revenue and Growth Rate (2015-2020)
7.3 Japan Theraputic Drug Monitorings Revenue and Growth Rate (2015-2020)
7.4 Korea Theraputic Drug Monitorings Revenue and Growth Rate (2015-2020)
7.5 India Theraputic Drug Monitorings Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Theraputic Drug Monitorings Revenue and Growth Rate (2015-2020)
8 South America Theraputic Drug Monitorings Revenue by Countries
8.1 South America Theraputic Drug Monitorings Revenue by Countries (2015-2020)
8.2 Brazil Theraputic Drug Monitorings Revenue and Growth Rate (2015-2020)
8.3 Argentina Theraputic Drug Monitorings Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Theraputic Drug Monitorings by Countries
9.1 Middle East & Africa Theraputic Drug Monitorings Revenue by Countries (2015-2020)
9.2 Saudi Arabia Theraputic Drug Monitorings Revenue and Growth Rate (2015-2020)
9.3 UAE Theraputic Drug Monitorings Revenue and Growth Rate (2015-2020)
9.4 Egypt Theraputic Drug Monitorings Revenue and Growth Rate (2015-2020)
9.5 South Africa Theraputic Drug Monitorings Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Theraputic Drug Monitorings Revenue and Market Share by Type (2015-2020)
10.2 Global Theraputic Drug Monitorings Market Forecast by Type (2019-2024)
10.3 Chemiluminescence Immunoassay (CLIA) Revenue Growth Rate (2015-2025)
10.4 Fluorescence Immunoassay (FPIA) Revenue Growth Rate (2015-2025)
10.5 Radioimmunoassay (RIA) Revenue Growth Rate (2015-2025)
10.6 Colorimetric Immunoassay Revenue Growth Rate (2015-2025)
10.7 Other Immunoassays Revenue Growth Rate (2015-2025)
11 Global Theraputic Drug Monitorings Market Segment by Application
11.1 Global Theraputic Drug Monitorings Revenue Market Share by Application (2015-2020)
11.2 Theraputic Drug Monitorings Market Forecast by Application (2019-2024)
11.3 Antiepileptic Drugs Revenue Growth (2015-2020)
11.4 Immunosuppressant Revenue Growth (2015-2020)
11.5 Antitumor Drugs Revenue Growth (2015-2020)
11.6 Psychotropic Drugs Revenue Growth (2015-2020)
11.7 Antibiotic Revenue Growth (2015-2020)
11.8 Antifungal Revenue Growth (2015-2020)
11.9 Cardiovascular Drugs Revenue Growth (2015-2020)
11.10 Antiasthmatic Revenue Growth (2015-2020)
11.11 Others Revenue Growth (2015-2020)
12 Global Theraputic Drug Monitorings Market Size Forecast (2021-2025)
12.1 Global Theraputic Drug Monitorings Market Size Forecast (2021-2025)
12.2 Global Theraputic Drug Monitorings Market Forecast by Regions (2021-2025)
12.3 North America Theraputic Drug Monitorings Revenue Market Forecast (2021-2025)
12.4 Europe Theraputic Drug Monitorings Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Theraputic Drug Monitorings Revenue Market Forecast (2021-2025)
12.6 South America Theraputic Drug Monitorings Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Theraputic Drug Monitorings Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Theraputic Drug Monitorings Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Theraputic Drug Monitorings by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Theraputic Drug Monitorings Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Theraputic Drug Monitorings Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Roche AG Corporate Information, Location and Competitors
Table 6. Roche AG Theraputic Drug Monitorings Major Business
Table 7. Roche AG Theraputic Drug Monitorings Total Revenue (USD Million) (2017-2018)
Table 8. Roche AG SWOT Analysis
Table 9. Roche AG Theraputic Drug Monitorings Product and Solutions
Table 10. Roche AG Theraputic Drug Monitorings Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. DiaSorin Corporate Information, Location and Competitors
Table 12. DiaSorin Theraputic Drug Monitorings Major Business
Table 13. DiaSorin Theraputic Drug Monitorings Total Revenue (USD Million) (2018-2019)
Table 14. DiaSorin SWOT Analysis
Table 15. DiaSorin Theraputic Drug Monitorings Product and Solutions
Table 16. DiaSorin Theraputic Drug Monitorings Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Beckman Coulter Corporate Information, Location and Competitors
Table 18. Beckman Coulter Theraputic Drug Monitorings Major Business
Table 19. Beckman Coulter Theraputic Drug Monitorings Total Revenue (USD Million) (2017-2018)
Table 20. Beckman Coulter SWOT Analysis
Table 21. Beckman Coulter Theraputic Drug Monitorings Product and Solutions
Table 22. Beckman Coulter Theraputic Drug Monitorings Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Siemens Healthineers Corporate Information, Location and Competitors
Table 24. Siemens Healthineers Theraputic Drug Monitorings Major Business
Table 25. Siemens Healthineers Theraputic Drug Monitorings Total Revenue (USD Million) (2017-2018)
Table 26. Siemens Healthineers SWOT Analysis
Table 27. Siemens Healthineers Theraputic Drug Monitorings Product and Solutions
Table 28. Siemens Healthineers Theraputic Drug Monitorings Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Sekisui Medical Corporate Information, Location and Competitors
Table 30. Sekisui Medical Theraputic Drug Monitorings Major Business
Table 31. Sekisui Medical Theraputic Drug Monitorings Total Revenue (USD Million) (2017-2018)
Table 32. Sekisui Medical SWOT Analysis
Table 33. Sekisui Medical Theraputic Drug Monitorings Product and Solutions
Table 34. Sekisui Medical Theraputic Drug Monitorings Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 36. Thermo Fisher Scientific Theraputic Drug Monitorings Major Business
Table 37. Thermo Fisher Scientific Theraputic Drug Monitorings Total Revenue (USD Million) (2017-2018)
Table 38. Thermo Fisher Scientific SWOT Analysis
Table 39. Thermo Fisher Scientific Theraputic Drug Monitorings Product and Solutions
Table 40. Thermo Fisher Scientific Theraputic Drug Monitorings Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Grifols Corporate Information, Location and Competitors
Table 42. Grifols Theraputic Drug Monitorings Major Business
Table 43. Grifols Theraputic Drug Monitorings Total Revenue (USD Million) (2017-2018)
Table 44. Grifols SWOT Analysis
Table 45. Grifols Theraputic Drug Monitorings Product and Solutions
Table 46. Grifols Theraputic Drug Monitorings Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. BioMérieux Corporate Information, Location and Competitors
Table 48. BioMérieux Theraputic Drug Monitorings Major Business
Table 49. BioMérieux Theraputic Drug Monitorings Total Revenue (USD Million) (2017-2018)
Table 50. BioMérieux SWOT Analysis
Table 51. BioMérieux Theraputic Drug Monitorings Product and Solutions
Table 52. BioMérieux Theraputic Drug Monitorings Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Agilent Technologies Corporate Information, Location and Competitors
Table 54. Agilent Technologies Theraputic Drug Monitorings Major Business
Table 55. Agilent Technologies Theraputic Drug Monitorings Total Revenue (USD Million) (2017-2018)
Table 56. Agilent Technologies SWOT Analysis
Table 57. Agilent Technologies Theraputic Drug Monitorings Product and Solutions
Table 58. Agilent Technologies Theraputic Drug Monitorings Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Fujirebio Corporate Information, Location and Competitors
Table 60. Fujirebio Theraputic Drug Monitorings Major Business
Table 61. Fujirebio Theraputic Drug Monitorings Total Revenue (USD Million) (2017-2018)
Table 62. Fujirebio SWOT Analysis
Table 63. Fujirebio Theraputic Drug Monitorings Product and Solutions
Table 64. Fujirebio Theraputic Drug Monitorings Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Chromsystems Corporate Information, Location and Competitors
Table 66. Chromsystems Theraputic Drug Monitorings Major Business
Table 67. Chromsystems Theraputic Drug Monitorings Total Revenue (USD Million) (2017-2018)
Table 68. Chromsystems SWOT Analysis
Table 69. Chromsystems Theraputic Drug Monitorings Product and Solutions
Table 70. Chromsystems Theraputic Drug Monitorings Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. ALPCO Corporate Information, Location and Competitors
Table 72. ALPCO Theraputic Drug Monitorings Major Business
Table 73. ALPCO Theraputic Drug Monitorings Total Revenue (USD Million) (2017-2018)
Table 74. ALPCO SWOT Analysis
Table 75. ALPCO Theraputic Drug Monitorings Product and Solutions
Table 76. ALPCO Theraputic Drug Monitorings Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Ortho-Clinical Diagnostics Corporate Information, Location and Competitors
Table 78. Ortho-Clinical Diagnostics Theraputic Drug Monitorings Major Business
Table 79. Ortho-Clinical Diagnostics Theraputic Drug Monitorings Total Revenue (USD Million) (2017-2018)
Table 80. Ortho-Clinical Diagnostics SWOT Analysis
Table 81. Ortho-Clinical Diagnostics Theraputic Drug Monitorings Product and Solutions
Table 82. Ortho-Clinical Diagnostics Theraputic Drug Monitorings Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. MedTox Corporate Information, Location and Competitors
Table 84. MedTox Theraputic Drug Monitorings Major Business
Table 85. MedTox Theraputic Drug Monitorings Total Revenue (USD Million) (2017-2018)
Table 86. MedTox SWOT Analysis
Table 87. MedTox Theraputic Drug Monitorings Product and Solutions
Table 88. MedTox Theraputic Drug Monitorings Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Bio-Rad Corporate Information, Location and Competitors
Table 90. Bio-Rad Theraputic Drug Monitorings Major Business
Table 91. Bio-Rad Theraputic Drug Monitorings Total Revenue (USD Million) (2017-2018)
Table 92. Bio-Rad SWOT Analysis
Table 93. Bio-Rad Theraputic Drug Monitorings Product and Solutions
Table 94. Bio-Rad Theraputic Drug Monitorings Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. Tosoh Corporate Information, Location and Competitors
Table 96. Tosoh Theraputic Drug Monitorings Major Business
Table 97. Tosoh Theraputic Drug Monitorings Total Revenue (USD Million) (2017-2018)
Table 98. Tosoh SWOT Analysis
Table 99. Tosoh Theraputic Drug Monitorings Product and Solutions
Table 100. Tosoh Theraputic Drug Monitorings Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. Quest Diagnostics Corporate Information, Location and Competitors
Table 102. Quest Diagnostics Theraputic Drug Monitorings Major Business
Table 103. Quest Diagnostics Theraputic Drug Monitorings Total Revenue (USD Million) (2017-2018)
Table 104. Quest Diagnostics SWOT Analysis
Table 105. Quest Diagnostics Theraputic Drug Monitorings Product and Solutions
Table 106. Quest Diagnostics Theraputic Drug Monitorings Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 107. BIOHIT Healthcare Theraputic Drug Monitorings Type and Application
Table 108. BIOHIT Healthcare Theraputic Drug Monitorings Major Business
Table 109. BIOHIT Healthcare Theraputic Drug Monitorings Total Revenue (USD Million) (2017-2018)
Table 110. BIOHIT Healthcare SWOT Analysis
Table 111. BIOHIT Healthcare Theraputic Drug Monitorings Product and Solutions
Table 112. BIOHIT Healthcare Theraputic Drug Monitorings Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 113. R-Biopharm AG Corporate Information, Location and Competitors
Table 114. R-Biopharm AG Theraputic Drug Monitorings Major Business
Table 115. R-Biopharm AG Theraputic Drug Monitorings Total Revenue (USD Million) (2017-2018)
Table 116. R-Biopharm AG SWOT Analysis
Table 117. R-Biopharm AG Theraputic Drug Monitorings Product and Solutions
Table 118. R-Biopharm AG Theraputic Drug Monitorings Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 119. Sysmex Corporate Information, Location and Competitors
Table 120. Sysmex Theraputic Drug Monitorings Major Business
Table 121. Sysmex Theraputic Drug Monitorings Total Revenue (USD Million) (2017-2018)
Table 122. Sysmex SWOT Analysis
Table 123. Sysmex Theraputic Drug Monitorings Product and Solutions
Table 124. Sysmex Theraputic Drug Monitorings Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 125. Wieslab Corporate Information, Location and Competitors
Table 126. Wieslab Theraputic Drug Monitorings Major Business
Table 127. Wieslab Theraputic Drug Monitorings Total Revenue (USD Million) (2017-2018)
Table 128. Wieslab SWOT Analysis
Table 129. Wieslab Theraputic Drug Monitorings Product and Solutions
Table 130. Wieslab Theraputic Drug Monitorings Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 131. Omnica Corporate Information, Location and Competitors
Table 132. Omnica Theraputic Drug Monitorings Major Business
Table 133. Omnica Theraputic Drug Monitorings Total Revenue (USD Million) (2017-2018)
Table 134. Omnica SWOT Analysis
Table 135. Omnica Theraputic Drug Monitorings Product and Solutions
Table 136. Omnica Theraputic Drug Monitorings Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 137. ARK Diagnostics Corporate Information, Location and Competitors
Table 138. ARK Diagnostics Theraputic Drug Monitorings Major Business
Table 139. ARK Diagnostics Theraputic Drug Monitorings Total Revenue (USD Million) (2017-2018)
Table 140. ARK Diagnostics SWOT Analysis
Table 141. ARK Diagnostics Theraputic Drug Monitorings Product and Solutions
Table 142. ARK Diagnostics Theraputic Drug Monitorings Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 143. Probe Scientific Corporate Information, Location and Competitors
Table 144. Probe Scientific Theraputic Drug Monitorings Major Business
Table 145. Probe Scientific Theraputic Drug Monitorings Total Revenue (USD Million) (2017-2018)
Table 146. Probe Scientific SWOT Analysis
Table 147. Probe Scientific Theraputic Drug Monitorings Product and Solutions
Table 148. Probe Scientific Theraputic Drug Monitorings Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 149. Global Theraputic Drug Monitorings Revenue (Million USD) by Players (2015-2020)
Table 150. Global Theraputic Drug Monitorings Revenue Share by Players (2015-2020)
Table 151. Global Theraputic Drug Monitorings Revenue (Million USD) by Regions (2015-2020)
Table 152. Global Theraputic Drug Monitorings Revenue Market Share by Regions (2015-2020)
Table 153. North America Theraputic Drug Monitorings Revenue by Countries (2015-2020)
Table 154. North America Theraputic Drug Monitorings Revenue Market Share by Countries (2015-2020)
Table 155. Europe Theraputic Drug Monitorings Revenue (Million USD) by Countries (2015-2020)
Table 156. Asia-Pacific Theraputic Drug Monitorings Revenue (Million USD) by Countries (2015-2020)
Table 157. South America Theraputic Drug Monitorings Revenue by Countries (2015-2020)
Table 158. South America Theraputic Drug Monitorings Revenue Market Share by Countries (2015-2020)
Table 159. Middle East and Africa Theraputic Drug Monitorings Revenue (Million USD) by Countries (2015-2020)
Table 160. Middle East and Africa Theraputic Drug Monitorings Revenue Market Share by Countries (2015-2020)
Table 161. Global Theraputic Drug Monitorings Revenue (Million USD) by Type (2015-2020)
Table 162. Global Theraputic Drug Monitorings Revenue Share by Type (2015-2020)
Table 163. Global Theraputic Drug Monitorings Revenue Forecast by Type (2021-2025)
Table 164. Global Theraputic Drug Monitorings Revenue by Application (2015-2020)
Table 165. Global Theraputic Drug Monitorings Revenue Share by Application (2015-2020)
Table 166. Global Theraputic Drug Monitorings Revenue Forecast by Application (2021-2025)
Table 167. Global Theraputic Drug Monitorings Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Theraputic Drug Monitorings Picture
Figure 2. Global Theraputic Drug Monitorings Revenue Market Share by Type in 2019
Figure 3. Chemiluminescence Immunoassay (CLIA) Picture
Figure 4. Fluorescence Immunoassay (FPIA) Picture
Figure 5. Radioimmunoassay (RIA) Picture
Figure 6. Colorimetric Immunoassay Picture
Figure 7. Other Immunoassays Picture
Figure 8. Theraputic Drug Monitorings Revenue Market Share by Application in 2019
Figure 9. Antiepileptic Drugs Picture
Figure 10. Immunosuppressant Picture
Figure 11. Antitumor Drugs Picture
Figure 12. Psychotropic Drugs Picture
Figure 13. Antibiotic Picture
Figure 14. Antifungal Picture
Figure 15. Cardiovascular Drugs Picture
Figure 16. Antiasthmatic Picture
Figure 17. Others Picture
Figure 18. Global Theraputic Drug Monitorings Revenue (USD Million) and Growth Rate (2015-2025)
Figure 19. North America Theraputic Drug Monitorings Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Europe Theraputic Drug Monitorings Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Asia-Pacific Theraputic Drug Monitorings Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. South America Theraputic Drug Monitorings Revenue (Million USD) and Growth Rate (2015-2025)
Figure 23. Middle East and Africa Theraputic Drug Monitorings Revenue (Million USD) and Growth Rate (2015-2025)
Figure 24. Global Theraputic Drug Monitorings Revenue (Million USD) and Growth Rate (2015-2025)
Figure 25. Global Theraputic Drug Monitorings Revenue Share by Players in 2019
Figure 26. Global Top 5 Players Theraputic Drug Monitorings Revenue Market Share in 2019
Figure 27. Global Top 10 Players Theraputic Drug Monitorings Revenue Market Share in 2019
Figure 28. Key Players Market Share Trend
Figure 29. Global Theraputic Drug Monitorings Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 30. Global Theraputic Drug Monitorings Revenue Market Share by Regions (2015-2020)
Figure 31. Global Theraputic Drug Monitorings Revenue Market Share by Regions in 2018
Figure 32. North America Theraputic Drug Monitorings Revenue and Growth Rate (2015-2020)
Figure 33. Europe Theraputic Drug Monitorings Revenue and Growth Rate (2015-2020)
Figure 34. Asia-Pacific Theraputic Drug Monitorings Revenue and Growth Rate (2015-2020)
Figure 35. South America Theraputic Drug Monitorings Revenue and Growth Rate (2015-2020)
Figure 36. Middle East and Africa Theraputic Drug Monitorings Revenue and Growth Rate (2015-2020)
Figure 37. North America Theraputic Drug Monitorings Revenue Market Share by Countries (2015-2020)
Figure 38. North America Theraputic Drug Monitorings Revenue Market Share by Countries in 2019
Figure 39. USA Theraputic Drug Monitorings Revenue and Growth Rate (2015-2020)
Figure 40. Canada Theraputic Drug Monitorings Revenue and Growth Rate (2015-2020)
Figure 41. Mexico Theraputic Drug Monitorings Revenue and Growth Rate (2015-2020)
Figure 42. Europe Theraputic Drug Monitorings Revenue Market Share by Countries (2015-2020)
Figure 43. Europe Theraputic Drug Monitorings Revenue Market Share by Countries in 2019
Figure 44. Germany Theraputic Drug Monitorings Revenue and Growth Rate (2015-2020)
Figure 45. UK Theraputic Drug Monitorings Revenue and Growth Rate (2015-2020)
Figure 46. France Theraputic Drug Monitorings Revenue and Growth Rate (2015-2020)
Figure 47. Russia Theraputic Drug Monitorings Revenue and Growth Rate (2015-2020)
Figure 48. Italy Theraputic Drug Monitorings Revenue and Growth Rate (2015-2020)
Figure 49. Asia-Pacific Theraputic Drug Monitorings Revenue Market Share by Countries (2015-2020)
Figure 50. Asia-Pacific Theraputic Drug Monitorings Revenue Market Share by Countries in 2019
Figure 51. China Theraputic Drug Monitorings Revenue and Growth Rate (2015-2020)
Figure 52. Japan Theraputic Drug Monitorings Revenue and Growth Rate (2015-2020)
Figure 53. Korea Theraputic Drug Monitorings Revenue and Growth Rate (2015-2020)
Figure 54. India Theraputic Drug Monitorings Revenue and Growth Rate (2015-2020)
Figure 55. Southeast Asia Theraputic Drug Monitorings Revenue and Growth Rate (2015-2020)
Figure 56. South America Theraputic Drug Monitorings Revenue Market Share by Countries (2015-2020)
Figure 57. South America Theraputic Drug Monitorings Revenue Market Share by Countries in 2019
Figure 58. Brazil Theraputic Drug Monitorings Revenue and Growth Rate (2015-2020)
Figure 59. Argentina Theraputic Drug Monitorings Revenue and Growth Rate (2015-2020)
Figure 60. Middle East and Africa Theraputic Drug Monitorings Revenue Market Share by Countries (2015-2020)
Figure 61. Middle East and Africa Theraputic Drug Monitorings Revenue Market Share by Countries in 2019
Figure 62. Saudi Arabia Theraputic Drug Monitorings Revenue and Growth Rate (2015-2020)
Figure 63. UAE Theraputic Drug Monitorings Revenue and Growth Rate (2015-2020)
Figure 64. Egypt Theraputic Drug Monitorings Revenue and Growth Rate (2015-2020)
Figure 65. South Africa Theraputic Drug Monitorings Revenue and Growth Rate (2015-2020)
Figure 66. Global Theraputic Drug Monitorings Revenue Share by Type (2015-2020)
Figure 67. Global Theraputic Drug Monitorings Revenue Share by Type in 2019
Figure 68. Global Theraputic Drug Monitorings Market Share Forecast by Type (2021-2025)
Figure 69. Global Chemiluminescence Immunoassay (CLIA) Revenue Growth Rate (2015-2020)
Figure 70. Global Fluorescence Immunoassay (FPIA) Revenue Growth Rate (2015-2020)
Figure 71. Global Radioimmunoassay (RIA) Revenue Growth Rate (2015-2020)
Figure 72. Global Colorimetric Immunoassay Revenue Growth Rate (2015-2020)
Figure 73. Global Other Immunoassays Revenue Growth Rate (2015-2020)
Figure 74. Global Theraputic Drug Monitorings Revenue Share by Application (2015-2020)
Figure 75. Global Theraputic Drug Monitorings Revenue Share by Application in 2019
Figure 76. Global Theraputic Drug Monitorings Market Share Forecast by Application (2021-2025)
Figure 77. Global Antiepileptic Drugs Revenue Growth Rate (2015-2020)
Figure 78. Global Immunosuppressant Revenue Growth Rate (2015-2020)
Figure 79. Global Antitumor Drugs Revenue Growth Rate (2015-2020)
Figure 80. Global Psychotropic Drugs Revenue Growth Rate (2015-2020)
Figure 81. Global Antibiotic Revenue Growth Rate (2015-2020)
Figure 82. Global Antifungal Revenue Growth Rate (2015-2020)
Figure 83. Global Cardiovascular Drugs Revenue Growth Rate (2015-2020)
Figure 84. Global Antiasthmatic Revenue Growth Rate (2015-2020)
Figure 85. Global Others Revenue Growth Rate (2015-2020)
Figure 86. Global Theraputic Drug Monitorings Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 87. Global Theraputic Drug Monitorings Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 88. Global Theraputic Drug Monitorings Revenue Market Share Forecast by Regions (2021-2025)
Figure 89. North America Theraputic Drug Monitorings Revenue Market Forecast (2021-2025)
Figure 90. Europe Theraputic Drug Monitorings Revenue Market Forecast (2021-2025)
Figure 91. Asia-Pacific Theraputic Drug Monitorings Revenue Market Forecast (2021-2025)
Figure 92. South America Theraputic Drug Monitorings Revenue Market Forecast (2021-2025)
Figure 93. Middle East and Africa Theraputic Drug Monitorings Revenue Market Forecast (2021-2025)
Figure 94. Sales Channel: Direct Channel vs Indirect Channel

---